AWT-041

N/A

Report date: 2026/05/27 17:57:55

Base Information

Drug NameAWT-041

Drug Alias NameAWT-041AWT041

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Vascular endothelial growth factorAnti-Programmed death-ligand 1

TargetsVascular endothelial growth factorProgrammed death-ligand 1

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAnwita Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesAnwita Biosciences Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A